Summit Therapeutics perceives multiple opportunities to expand across the microbiome therapeutics field Cambridge, MA, March…
REDWOOD CITY, Calif., March 17, 2022 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a…
FREMONT, Calif., March 17, 2022 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company,…
SEATTLE, March 17, 2022 (GLOBE NEWSWIRE) — Impel NeuroPharma (NASDAQ: IMPL), a commercial-stage pharmaceutical company…
On track to announce initial Phase 1 clinical trial data from two co-lead programs in…
Phase 3 (FREEDOM-1) clinical trial in living donor kidney transplant (LDKT) patients continues; additional data…
SEATTLE, March 17, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company…
Combined company expected to have a pro forma equity value post-money of approximately $1.64 billion,…
Revenue increased by 38% to $44 million for the quarter and by 237% for the…
NEW YORK & CHARLOTTE, N.C.–(BUSINESS WIRE)–Sunlight Financial (“Sunlight”) (NYSE: SUNL), a premier, technology-enabled point-of-sale financing…
NEW YORK–(BUSINESS WIRE)–#KBRA–Kroll Bond Rating Agency (KBRA) assigns preliminary ratings to 61 classes of mortgage…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA is pleased to announce the assignment of preliminary ratings to 17 classes…
Delivers Record Revenue and Profitability Repurchased $23 million in Common Stock Under Stock Repurchase Program…
Revenue of $145.6 million for the year ended December 31, 2021 Gross margin of 23%…
NEW YORK–(BUSINESS WIRE)–The Board of Directors of Annaly Capital Management, Inc. (NYSE: NLY) (“Annaly” or…
HILLSBORO, Ore.–(BUSINESS WIRE)–$LSCC #AIML—Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that…
Continued Execution of Cloud Growth Strategy Drives 35% Increase in SaaS Revenue and 16% Increase…
New investment will accelerate development of new battery chemical manufacturing CLEVELAND–(BUSINESS WIRE)–#batteries–Octet Scientific, Inc., a…
Leuven, Belgium, Boston, MA, US – March 17, 2022 – 07.00 PM CET – Oxurion…
Michael MOUREZ joins the DEINOVE team as Chief Innovation Officer DEINOVE (Euronext Growth Paris: ALDEI),…